Skip to main content
HairCited

螺内酯（Spironolactone） 图表

5 来自同行评审研究的图表

全部 L-半胱氨酸 MSM（甲基磺酰甲烷） Omega-3 脂肪酸 PRP 疗法 低能量激光疗法（LLLT） 咖啡因（外用） 度他雄胺（Dutasteride） 微针疗法 硒 米诺地尔（Minoxidil） 维生素 B12 维生素 D 胶原蛋白 螺内酯（Spironolactone） 角蛋白（Keratin） 迷迭香精油 铁 锌 非那雄胺（Finasteride）
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)
Figure 7

A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Figure 3
Figure 3

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 4
Figure 4

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 5
Figure 5

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.
Figure 6

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …